Alnylam, with positive data on second gene-silencing drug, plans filing to FDA

Alnylam, with positive data on second gene-silencing drug, plans filing to FDA

By ANDREW JOSEPH

LANE TURNER/THE BOSTON GLOBE

The company said it hopes to file with the Food and Drug Administration for accelerated approval of the drug, givosiran, likely by the end of the year.

READ MORE